Quality Management Center, Tokyo Medical and Dental University, Yushima 1-5-45, Bunkyo, Tokyo, 113-8510, Japan.
Department of Women's Health, Tokyo Medical and Dental University, Yushima 1-5-45, Bunkyo, Tokyo, 113-8510, Japan.
J Bone Miner Metab. 2022 Sep;40(5):748-754. doi: 10.1007/s00774-022-01336-4. Epub 2022 Jun 12.
Pregnancy- and lactation-associated osteoporosis (PLO) is a condition in which young women develop fractures during pregnancy or breastfeeding. Though PLO is a severely debilitating disease, its pathophysiology and epidemiology have not been clarified and its treatment has not been established. We aimed to identify the incidence and factors associated with fractures occurring within 2 years following an obstetric hospitalization.
We extracted data on fractures occurring within 2 years of an obstetric hospitalization from the Japanese Diagnosis Procedure Combination database. We analyzed the implementation of bone mineral density and bone metabolism marker tests, prescription status, and factors associated with fractures occurring within 2 years of an obstetric hospitalization.
Among 837,347 patients with a history of obstetric hospitalization from 2010 to 2014, 379 patients had a history of hospitalization due to a fracture occurring within 2 years (4.5/10,000 pregnancies). Among the patients with fractures occurring within 2 years of an obstetric hospitalization, 6.7% underwent bone mineral quantification or a bone metabolism marker test, and 7.5% were prescribed a lactation inhibitor or osteoporosis treatment. Factors associated with fractures occurring within 2 years following an obstetric hospitalization identified included Cushing syndrome, Charlson Comorbidity Index score ≥ 1, age ≥ 40 years old at pregnancy, smoking history, and steroid administration.
We investigated fracture cases occurring within 2 years of an obstetrics hospitalization. This finding may be useful in selecting preventative measures for patients at risk of fractures within 2 years after obstetric hospitalization, including PLO.
妊娠和哺乳期骨质疏松症(PLO)是一种年轻女性在妊娠或哺乳期发生骨折的疾病。尽管 PLO 是一种严重的致残性疾病,但它的病理生理学和流行病学尚未阐明,其治疗方法也尚未建立。我们旨在确定与产科住院后 2 年内发生骨折相关的发病率和因素。
我们从日本诊断程序组合数据库中提取了产科住院后 2 年内发生骨折的病例数据。我们分析了骨密度和骨代谢标志物检测、处方状况以及与产科住院后 2 年内发生骨折相关的因素的实施情况。
在 2010 年至 2014 年有产科住院史的 837347 名患者中,有 379 名患者因 2 年内发生的骨折住院(4.5/10000 例妊娠)。在产科住院后 2 年内发生骨折的患者中,6.7%进行了骨矿物质定量或骨代谢标志物检测,7.5%开了哺乳期抑制剂或骨质疏松症治疗药物。与产科住院后 2 年内发生骨折相关的因素包括库欣综合征、Charlson 合并症指数评分≥1、妊娠时年龄≥40 岁、吸烟史和类固醇治疗。
我们调查了产科住院后 2 年内发生的骨折病例。这一发现可能有助于为产科住院后 2 年内有骨折风险的患者选择预防措施,包括 PLO。